Generics account for 32% greater market share since Medicare Part D

7 March 2017
drugs_pills_tablets_big

Created in the Medicare Modernization Act of 2003, and formally implemented in 2006, a US program aimed at providing affordable prescription drugs to seniors and people living with disabilities has had a dramatic impact, a study shows.

This research, published in the International Journal of Health Economics and Management, looks at the effect of Medicare Part D, in particular on physician prescribing.

The study shows that there has been a 46% increase in the number of generic drugs prescribed or continued for the elderly after the introduction of Part D.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Generics